Literature DB >> 4273715

Localization of 14C-pancuronium by histo- and wholebody-autoradiography in normal and pregnant mice.

P G Waser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4273715     DOI： 10.1007/bf00500805

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  6 in total

1.  Effects of pancuronium bromide on the motor nerve terminal.

Authors:  K L Dretchen; M D Sokoll; S D Gergis; J P Long
Journal:  Eur J Pharmacol       Date:  1972-10       Impact factor: 4.432

2.  Dose-Response curves for tubocurarine, alcuronium and pancuronium.

Authors:  I Lund; J Stovner
Journal:  Acta Anaesthesiol Scand Suppl       Date:  1969

3.  The pharmacology of pancuronium bromide (Org.NA97), a new potent steroidal neuromuscular blocking agent.

Authors:  W R Buckett; C E Marjoribanks; F A Marwick; M B Morton
Journal:  Br J Pharmacol Chemother       Date:  1968-03

4.  Distribution and pharmacokinetics of 14 C-toxiferine in rats.

Authors:  P G Waser; J Reller
Journal:  Agents Actions       Date:  1972-06

5.  Studies of pancuronium in conscious and anesthetized man.

Authors:  F F Foldes; D H Klonymus; W Maisel; F Sciammas; T Pan
Journal:  Anesthesiology       Date:  1971-11       Impact factor: 7.892

6.  The neuromuscular blocking properties of a new steroid compound, pancuronium bromide. A pilot study in man.

Authors:  W L Baird; A M Reid
Journal:  Br J Anaesth       Date:  1967-10       Impact factor: 9.166
  6 in total
  10 in total

Review 1.  Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations.

Authors:  D K Meijer; W E Mol; M Müller; G Kurz
Journal:  J Pharmacokinet Biopharm       Date:  1990-02

Review 2.  Pharmacokinetics in intravenous anaesthetic practice.

Authors:  P Duvaldestin
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of the non-depolarising muscle relaxants.

Authors:  M I Ramzan; A A Somogyi; J S Walker; C A Shanks; E J Triggs
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

4.  Quantitative correlation between complete block of nicotinic acetylcholine receptors and saturation of the motor endplate with 14C-toxiferine.

Authors:  C G Caratsch; P G Waser; C Spiess; E Schönenberger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-01       Impact factor: 3.000

5.  Tissue distribution of 14C-heteronium bromide: radioactivity levels at different time intervals after oral administration in the rat.

Authors:  U Traversa; L de Angelis; R Vertua
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-08       Impact factor: 3.000

6.  Selective binding of aldrin and dieldrin in cartilage.

Authors:  I Brandt; P G Högman
Journal:  Arch Toxicol       Date:  1980-09       Impact factor: 5.153

7.  Pharmacokinetics of pancuronium in patients undergoing coronary artery surgery with and without low dose dopamine.

Authors:  J M Wierda; P J van der Starre; A H Scaf; W D Kloppenburg; J H Proost; S Agoston
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

8.  Pharmacokinetics of pancuronium in man: a linear system.

Authors:  P Duvaldestin; M Demetriou; A D'Hollander
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

9.  Pancuronium blood level monitoring in patients with tetanus.

Authors:  P Duvaldestin; C Gibert; D Henzel; P Guy; J M Desmonts
Journal:  Intensive Care Med       Date:  1979-09       Impact factor: 17.440

10.  An analytical pharmacodynamic model for nondepolarizing neuromuscular blocking agents.

Authors:  A d'Hollander; C Delcroix
Journal:  J Pharmacokinet Biopharm       Date:  1981-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.